29. CASH FLOW INFORMATION
30. FINANCIAL RISK MANAGEMENT
The group’s nancial instruments consist mainly of cash at bank, payables and receivables.
The group has not formulated any specic management objectives and policies in respect to debt nancing, derivatives or hedging
activity. As a result, the group has not formulated any specic management objectives and policies in respect to these types of nancial
instruments. Should the group change its position in the future, a considered summary of these policies will be disclosed at that time.
The Group’s current exposure to the risk of changes in the market is managed by the Board of Directors.
Market risks
The Group is exposed to a variety of nancial risks through its nancial instruments for example, interest rate risk, liquidity risk and
credit risk, as well as foreign currency risk.
Interest rate risk
At reporting date, the Group does not have long term borrowings and its exposure to interest rate risk is assessed as low. The risk
monitors its interest rate risk through sensitivity analysis, as outlined below.
The consolidated group’s exposure to interest rate risk which is the risk that a nancial instrument’s value will uctuate as a result
of changes in market interest rates and the effective weighted average interest rates on classes of nancial assets of the group are
summarised in the following tables:
Notes to the Financial Statements
Changes in assets and liabilities, net of the effects of
purchase of subsidiaries
(Increase) in inventory
(Increase) in trade and other receivables
Increase in trade payables and accruals
Cash ow from operations
mgcpharma.com.au
64